Site Search
Google Search
Breaking News: Amazon Go The Future Of Groceries?     - | -     President of Ecuador Rips Julian Assange     - | -     Homicides in Mexico Peak in 2017     - | -     Volcano In Philippines Prompts Evacuation Of 27,000     - | -     GOP Congressman Invokes 'The Deep State'
Pfizer Ends Research for New Alzheimer's, Parkinson's Drugs
Get Business & Technology Alerts

7 Jan 2018 07:37 PM EST

NEW YORK (Reuters) - Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes the money spent on research, according to the emailed statement. Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY